No Cover Image

Journal article 548 views

Azole Resistance by Loss of Function of the Sterol {Delta}5,6-Desaturase Gene (ERG3) in Candida albicans Does Not Necessarily Decrease Virulence. / LA Vale-Silva; AT Coste; F Ischer; JE Parker; SL Kelly; E Pinto; D Sanglard; Steven Kelly

Antimicrob.Agents.Chemother., Volume: 56, Issue: 4, Pages: 1960 - 1968

Swansea University Author: Steven, Kelly

Abstract

The inactivation of ERG3, a gene encoding sterol Δ(5,6)-desaturase (essential for ergosterol biosynthesis), is a known mechanism of in vitro resistance to azole antifungal drugs in the human pathogen Candida albicans. ERG3 inactivation typically results in loss of filamentation and attenuated virule...

Full description

Published in: Antimicrob.Agents.Chemother.
Published: AMER.SOC.MICROBIOL. 2012
URI: https://cronfa.swan.ac.uk/Record/cronfa10674
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: The inactivation of ERG3, a gene encoding sterol Δ(5,6)-desaturase (essential for ergosterol biosynthesis), is a known mechanism of in vitro resistance to azole antifungal drugs in the human pathogen Candida albicans. ERG3 inactivation typically results in loss of filamentation and attenuated virulence in animal models of disseminated candidiasis. In this work, we identified a C. albicans clinical isolate (VSY2) with high-level resistance to azole drugs in vitro and an absence of ergosterol but normal filamentation. Sequencing of ERG3 in VSY2 revealed a double base deletion leading to a premature stop codon and thus a nonfunctional enzyme. The reversion of the double base deletion in the mutant allele (erg3-1) restored ergosterol biosynthesis and full fluconazole susceptibility in VSY2, confirming that ERG3 inactivation was the mechanism of azole resistance. Additionally, the replacement of both ERG3 alleles by erg3-1 in the wild-type strain SC5314 led to the absence of ergosterol and to fluconazole resistance without affecting filamentation. In a mouse model of disseminated candidiasis, the clinical ERG3 mutant VSY2 produced kidney fungal burdens and mouse survival comparable to those obtained with the wild-type control. Interestingly, while VSY2 was resistant to fluconazole both in vitro and in vivo, the ERG3-derived mutant of SC5314 was resistant only in vitro and was less virulent than the wild type. This suggests that VSY2 compensated for the in vivo fitness defect of ERG3 inactivation by a still unknown mechanism(s). Taken together, our results provide evidence that contrary to previous reports inactivation of ERG3 does not necessarily affect filamentation and virulence.
College: Swansea University Medical School
Issue: 4
Start Page: 1960
End Page: 1968